|
Diabetes, Vol 48, Issue 3 603-608, Copyright © 1999 by American Diabetes Association
Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes
H Schmid, LA Forman, X Cao, PS Sherman and MJ Stevens
Department of Internal Medicine, University of Michigan, Ann Arbor 48109-0678, USA.
Heterogeneous myocardial sympathetic denervation complicating diabetes has
been invoked as a factor contributing to sudden unexplained cardiac death.
In subjects with diabetic autonomic neuropathy (DAN), distal left
ventricular (LV) denervation contrasts with preservation of islands of
proximal innervation, which exhibit impaired vascular responsiveness. The
aims of this study were to determine whether this heterogeneous pattern of
myocardial sympathetic denervation occurs in a rat model of diabetes and to
explore a potential association with regional fluctuations in myocardial
nerve growth factor (NGF) protein. Myocardial sympathetic denervation was
characterized scintigraphically using the sympathetic neurotransmitter
analog C-11 hydroxyephedrine ([11C]HED) and compared with regional changes
in myocardial NGF protein abundance and norepinephrine content after 6 and
9 months in nondiabetic (ND) and streptozotocin-induced diabetic (STZ-D)
rats. In ND rats, no difference in [11C]HED retention or norepinephrine
content was detected in the proximal versus distal myocardium. After 6
months, compared with ND rats, myocardial [11C]HED retention had declined
in the proximal segments of STZ-D rats by only 9% (NS) compared with a 33%
decrease in the distal myocardium (P < 0.05). Myocardial norepinephrine
content was similar in both ND and STZ-D rats. At 6 months, LV myocardial
NGF protein content in STZ-D rats decreased by 52% in the proximal
myocardial segments (P < 0.01 vs. ND rats) and by 82% distally (P <
0.01 vs. ND rats, P < 0.05 vs. proximal segments). By 9 months, [11C]HED
retention had declined in both the proximal and distal myocardial segments
of the STZ-D rats by 42% (P < 0.01 vs. ND rats), and LV norepinephrine
content and NGF protein were decreased in parallel. Therefore, 6 months of
STZ-induced diabetes results in heterogeneous cardiac sympathetic
denervation in the rat, with maximal denervation occurring distally, and is
associated with a proximal-to-distal gradient of LV NGF protein depletion.
It is tempting to speculate that regional fluctuations of NGF protein in
the diabetic myocardium contribute to heterogeneous cardiac sympathetic
denervation complicating diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Feng, D. B. Hoover, and N. Paolocci
Forever Young?: Nerve Growth Factor, Sympathetic Fibers, and Right Ventricle Pressure Overload
Circ. Res.,
June 22, 2007;
100(12):
1670 - 1672.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ieda, H. Kanazawa, Y. Ieda, K. Kimura, K. Matsumura, Y. Tomita, T. Yagi, T. Onizuka, K. Shimoji, S. Ogawa, et al.
Nerve Growth Factor Is Critical for Cardiac Sensory Innervation and Rescues Neuropathy in Diabetic Hearts
Circulation,
November 28, 2006;
114(22):
2351 - 2363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Bengel, P. Ueberfuhr, D. Schafer, S. G. Nekolla, B. Reichart, and M. Schwaiger
Effect of Diabetes Mellitus on Sympathetic Neuronal Regeneration Studied in the Model of Transplant Reinnervation
J. Nucl. Med.,
September 1, 2006;
47(9):
1413 - 1419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pop-Busui, I. Kirkwood, H. Schmid, V. Marinescu, J. Schroeder, D. Larkin, E. Yamada, D. M. Raffel, and M. J. Stevens
Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction
J. Am. Coll. Cardiol.,
December 21, 2004;
44(12):
2368 - 2374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Y. Fang, J. B. Prins, and T. H. Marwick
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Endocr. Rev.,
August 1, 2004;
25(4):
543 - 567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Canty Jr and J. A. Fallavollita
Sympathetic Nerves and Myocyte Necrosis: More Than Meets the Eye
Circ. Res.,
October 31, 2003;
93(9):
796 - 798.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Mei, T. O. Mundinger, A. Lernmark, and G. J. Taborsky Jr
Early, Selective, and Marked Loss of Sympathetic Nerves From the Islets of BioBreeder Diabetic Rats
Diabetes,
October 1, 2002;
51(10):
2997 - 3002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Pietrzyk, S. Vogel, G. J. Dietze, and S. F. Rabito
Augmented Sympathetic Response to Bradykinin in the Diabetic Heart Before Autonomic Denervation
Hypertension,
August 1, 2000;
36(2):
208 - 214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Qin, R. S. Vulapalli, S. Y. Stevens, and C.-S. Liang
Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF
Am J Physiol Heart Circ Physiol,
January 1, 2002;
282(1):
H363 - H371.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|